Ionotropic glutamate receptors are essential for fast synaptic nerve transmission. Recent x-ray structures for the ligand-binding (S1S2) region of the GluR2 ␣-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive receptor have suggested how differences in protein/ligand interactions may determine whether a ligand will behave as a full agonist. We have used multiple molecular dynamics simulations of 2-5 ns duration to explore the structural dynamics of GluR2 S1S2 in the presence and absence of glutamate and in a complex with kainate. Our studies indicate that not only is the degree of domain closure dependent upon interactions with the ligand, but also that protein/ligand interactions influence the motion of the S2 domain with respect to S1. Differences in domain mobility between the three states (apo-S1S2, glutamate-bound, and kainate-bound) are surprisingly clear-cut. We discuss how these changes in dynamics may provide an explanation relating the mechanism of transmission of the agonist-binding event to channel opening. We also show here how the glutamate may adopt an alternative mode of binding not seen in the x-ray structure, which involves a key threonine (T480) side chain flipping into a new conformation. This new conformation results in an altered pattern of hydrogen bonding at the agonist-binding site.
INTRODUCTION
Fast synaptic transmission between nerve cells in mammals is carried out predominantly by ionotropic glutamate receptors (iGluR). These receptors are a family of ligand-gated ion channels that open in response to the binding of glutamate (Dingledine et al., 1999; Sprengel et al., 2001) . Glutamate is released presynaptically and binds to a postsynaptic receptor gating a cation-selective channel, thus depolarizing the post-synaptic cell. Although glutamate is the natural ligand, the various iGluRs identified by sequence comparisons may also be classified in terms of their agonist pharmacology (Hollmann and Heinemann, 1994) . Those receptors (GluR1-4) that show greatest sensitivity to the synthetic agonist ␣-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) are termed AMPA receptors (Borges and Dingledine, 1998) . Likewise, those that show greatest sensitivity to kainate (GluR5-7 and KA1-2) are referred to as kainate receptors (Lerma et al., 1997; Chittajallu et al., 1999) . Receptors activated by the synthetic N-methyl-D-aspartate (NMDAR1 and NMDAR2a-d) are called NMDA receptors (Yamakura and Shimoji, 1999) and need glycine and glutamate as the natural agonist. In all of these GluRs the agonist/antagonist binding site is located within the extracellular (EC) region of the protein (Fig. 1) . Preceding the glutamate-binding domains is an amino-terminal domain (ATD). This has ϳ16% sequence identity to the bacterial leucine/isoleucine/valine-binding protein (O'Hara et al., 1993) . Although the ATD is not directly involved in ligand binding, it has been shown to be important for subtype-specific interactions (Leuschner and Hoch, 1999) . The polypeptide chain then proceeds to make up most of domain S1 of the ligand-binding site before forming two transmembrane (TM) helices (M1 and M2) and an intervening P-loop, suggestive of an inverted potassium channel TM architecture (Panchenko et al., 2001) . As it leaves M2 the polypeptide chain then forms most of domain S2 in the ligand-binding cleft before forming a third TM helix, M3, followed by a short C-terminus. The x-ray structure of a water-soluble construct corresponding to the ligand-binding domains (S1S2) of the EC region of GluR2 was first solved by Armstrong et al. (1998) , revealing the agonist-binding site to lie at the interface between S1 and S2.
Evidence from single-channel recordings on homomeric GluR4(i) receptors showed that currents elicited by kainate as the agonist were up to eightfold smaller than those elicited by AMPA or glutamate (Smith et al., 2000) . Hence, kainate may be thought of as a partial agonist of the AMPA receptor. Recently, a series of high-resolution crystal structures of different agonists and of an antagonist (DNQX) bound to the GluR2 ligand-binding domain was published (Armstrong and Gouaux, 2000) . Comparison of these structures of the AMPA-and glutamate-bound complexes revealed a domain closure of ϳ20°relative to the apo state. In contrast, the partial agonist kainate induced a domain closure of only ϳ12°.
Although it is evident that inter-domain movement occurs upon ligand binding, x-ray structures provide only static snapshots of a dynamic process. In this paper we use molecular dynamics (MD) simulations to explore changes in the conformational dynamics of the GluR2 ligand-binding construct in response to different patterns of binding-site occupancy, i.e., no ligand versus full agonist (glutamate) versus partial agonist (kainate). These simulations provide an insight into agonist dependency of the dynamics of the ligand-binding construct on a multi-nanosecond timescale.
METHODS
Crystal structures (Armstrong and Gouaux, 2000) for the glutamate (1FTJ), kainate (1FWO), and the apo (1FTO) states of the S1S2 construct were downloaded from www.rcsb.org. The 1FTJ coordinate set of the glutamatebound state was used to generate an additional apo state (hereafter referred to as Apo2) from which the glutamate was removed and the binding site solvated with five additional water molecules (Table 1) . We use the same residue numbering as that employed by Armstrong and Gouaux (2000) for ease of comparison. Missing residues were added using the molecular editor in Quanta (Accelrys, San Diego, CA) and the N-and C-termini were acetylated and amidated, respectively, to mimic the continuation of the protein chain. Before MD simulations were started, we performed pK A calculations (Adcock et al., 1998) to determine whether any of the bindingsite residues were likely to adopt nonstandard ionization states. On the basis of the results of these calculations, all residues were modeled in their default ionization states.
Crystallographic waters within 4 Å of the protein were retained. Each of the three starting structures (glutamate-bound, kainate-bound, and apo) were solvated by a box of ϳ11,000 simple point charge (SPC) (Hermans et al., 1984) water molecules (Table 1 ) and the appropriate number of counterions were added to ensure overall neutrality of the system. The protein and ligands were then subjected to a restrained run of 200 ps, whereby the protein (and ligand if present) were harmonically restrained with a force of 1000 kJ mol Ϫ1 . After this period all restraints were removed and the simulations run for 2 ns. For simulation of Apo2 this was extended to 5 ns. Electrostatics were calculated using particle mesh Ewald (PME) (Darden et al., 1993; Essman et al., 1995) with a 10-Å cutoff. The temperature was coupled with the Berendsen thermostat , at 300 K with T ϭ 0.1 ps. The time step for integration was 2 fs, and coordinates and velocities were saved every 5 ps. The LINCS (Hess et al., 1997) algorithm was used to restrain bond lengths. All simulations were performed using GROMACS (http://rugmd0.chem.rug.nl/ϳgmx/index.html) (Berendsen et al., 1995) running on a Silicon Graphics Origin 2000 computer.
RESULTS

Domain closure and inter-domain motions
Comparison of the crystal structures of the S1S2 construct with and without agonists (Armstrong and Gouaux, 2000) suggested that the degree of domain closure between the two domains could be responsible for differences in the effectiveness of ligands as agonists. In our MD simulations we wanted to explore this aspect further in terms of the intra-and inter-domain motion and of how the motion of the domains is influenced by the ligand.
The drift of each simulated structure from its initial crystallographic conformation provides information on the quality of the simulations. The drift was measured in terms of the root mean square deviation (RMSD) of the C␣ atoms from the initial structures as a function of time. For the three (Apo1, Glu1, and Kai) simulations after an initial rise (during the first ϳ300 ps) the C␣ RMSD plateaus at ϳ1.25 Å (data not shown). This is indicative of a stable simulation. To obtain an initial estimate of the relative motions of the FIGURE 1 (A) Overall topology of the Glu-R2 protein. ATD represents the amino-terminal domain (thought to be involved in tetramerization of the receptor). S1 and S2 are the two domains that make up the region that binds the ligand (L), i.e., glutamate. M1, P, M2, and M3 make up the transmembrane region of each subunit. (B) X-ray structure of the S1-S2 construct (Armstrong and Gouaux, 2000) . The linker region is indicated by a black rod. The bilobal domain architecture is marked by the dashed line, with the S1 domain above and the S2 domain below this line. The ligand-binding site is shown occupied by glutamate. Figure drawn with Molscript (Kraulis, 1991) and POV-ray (http://www.povray.org). *In Glu2, protomer C from the x-ray structure was employed, which has the peptide bond between Asp651 and Ser652 in a flipped conformation, whereas simulation Glu1 used protomer A, in which (as in all of the other simulations) the 651-652 bond is not flipped (see main text for further details).
two domains during the 2 ns, we determined the C␣ RMSD of the second domain (S2) after fitting the S1 domain C␣ atoms to the initial structure(s) ( Fig. 2 A) . In this case the domain S2 C␣ RMSDs for the Glu1 and Kai simulations plateau at ϳ1.5 Å after 300 ps. In contrast, the Apo1 simulation shows a C␣ RMSD, which rises to ϳ3 Å and exhibits much greater fluctuations than for either of the liganded states. This comparison can be extended by fitting the domain S1 protein coordinates (saved every 20 ps) on top of the initial structure(s) and examining the backbone traces of the protein (Fig. 2 B) . From this diagram it is evident that there is a progressive increase in the motion of domain S2 (relative to domain S1) from Glu1 to Kai to Apo1. This suggests that the full agonist results in greater immobilization of the domains relative to one another than does the partial agonist. This is in addition to differences in the degree of (static) domain closure observed in the x-ray structures (Armstrong and Gouaux, 2000) .
A further measure of the quality of our simulations is provided by comparison of temperature (B) factors calculated from simulation root mean square fluctuations (RMSFs) with those determined experimentally in the x-ray diffraction studies. We found good agreement of the calculated B-factors from the simulation with those reported in the crystallographic structures. A couple of residues located on the outer surface loops had values higher than those reported, but generally the simulated values were consistently lower than the experimental values by ϳ5 Å 2 . Given we observed a significant difference in inter-domain motion induced by different ligands, we wished to reassure ourselves that the mean conformation of the protein in our simulations retained the domain closure seen in the crystal structures. Therefore, we determined inter-domain distance matrices averaged over the whole duration of each simulation (Fig. 3) . These quite clearly reveal the gradient in inter-domain contacts between the Apo1 simulation (fewest contacts) and the Glu1 simulation (most contacts). The mean distances of these contacts are in accord with the mean degree of domain closure observed in the crystal structures, indicating that the average behavior in the MD simulations reproduces the crystallographic averages. As an additional check we compared the radius of gyration (of the C␣ atoms) for each of the simulations to provide a measure of the overall compactness of the protein. A clear distinction can be seen between the mean radius of gyration (R GYR ) for the three different simulations with Apo1 (R GYR Ϸ 19.2 Å) Ͼ Kai (R GYR Ϸ 18.7 Å) Ͼ Glu1 (R GYR Ϸ 18.4 Å). Furthermore, the fluctuations in the radius of gyration are much greater for Apo1, again indicative of significant interdomain motion. Thus, this analysis supports the conclusion reached by visualization of the inter-domain motions.
Apo2 simulation
We have also performed a simulation (Apo2) starting from the conformation of the protein observed in the crystal structure with glutamate bound, but with the ligand removed and replaced by water molecules (see above). Thus the protein is in the domains-closed state, but without any stabilizing ligand. This simulation was run for 5 ns. Even on this timescale we did not see any evidence of net movement of the domains relative to one another to yield a conformation resembling that in Apo1. We suspect that much longer simulations (Ͼ100 ns) might be required to see such a conformational change, although domain motions have on occasions been seen in ϳ2-ns simulations (Roccatano et al., 2001) .
We have applied the various analyses described above to the Apo2 simulation. The drift from the initial structure seen in the RMSD plots is similar to that observed for the Glu1 simulation, implying that the protein maintains a conformation that is similar to the glutamate-bound state. The radius of gyration for the Apo2 simulation is ϳ18.4 Å across the whole 5 ns, which is identical to the value observed for the Glu1 simulation. 
Multiple peptide bond conformations
In their analysis of the crystal forms, Armstrong et al. (1998) observed a flip in the peptide bond between Asp651 and Ser652 for the AMPA-bound and in one of three glutamate-bound protomers. They suggested that the switch of this residue from an unflipped to a flipped conformation was related to receptor activation. Our initial simulation (Glu1) was based upon protomer A, which in the crystal was observed in an unflipped conformation. During the 2-ns Glu1 simulation we did not observe any change in the backbone torsion ( and ) angles in this region. We investigated this aspect further by running a simulation (Glu2; see Table 1 ) starting from protomer C, which has the flipped conformation of the peptide bond. Within 600 ps, we observed the angle of Ser652 to rotate through ϳ50 -60°( Fig. 4) and remain in that new conformation for the remainder of the simulation. The new conformation is closer to the protomer B conformation in the crystal. Thus, our simulations suggest that in the presence of glutamate, multiple conformations of the Ser652 can exist, as in the x-ray structure. Although it has been postulated that this flipping could be related to receptor activation it is very difficult to make any conclusion with respect to the mechanism for two reasons. The first is the timescale of this simulation with respect to the timescale of activation; such a mechanism of activation must involve conformation changes in the region of the linker, for to observe such a propagation of conformational change would require multiple long simulations. Second, it could be that the presence of the linker in this region alone infers different conformation changes than that which occur in the fulllength receptor.
The overall R GYR for the Glu2 simulation was 18.4 Å, i.e., identical to that observed for the Glu1 simulation. Our analysis of the RMSD plots also indicated that the overall behavior of the protein in Glu2 was similar to that in the Glu1 simulation.
Binding modes
What is the main distinction between glutamate (a full agonist) and kainate (a partial agonist)? The answer must lie within their manners of binding. We thus examined in detail interactions at the binding sites in the Glu1 and Kai simulations. The binding site is comprised of an intricate network of hydrogen bonds (Fig. 5 ). It can be seen that the key interactions of domain S1 involving Arg485, Thr480, and Pro478 are seen with both ligands as are the key interactions of domain S2 involving Ser654, Thr655, and Glu705. We have monitored the existence and duration of these key H-bond interactions throughout the Glu1 and Kai simulations (Glu1 and Kai; Fig. 6 ). Distinct differences are observed between the two ligands in terms of the hydrogenbond lifetimes. For both ligands, Arg485 is observed to maintain the largest number of contacts for long lifetimes in agreement with the observation (Armstrong and Gouaux, 2000) that this residue is the primary anchor for the ␣-carboxyl group of the ligand and with experiments indicating that mutations of this residue invariably lead to loss of function (Uchino et al., 1992; Wafford et al., 1995; Kawamoto et al., 1997) . However, there are also some clear differences between the two ligands. In simulation, Glu1 H-bond analysis revealed two additional long-lived interactions, not present in the starting structure. These appeared after 1 ns and were between 1) the NH of Glu and the Thr480 backbone OG atom and 2) the glutamate O and the Arg485 side-chain NH. This was examined closer and was found to be due to flipping (by ϳ100°) around the C␣-C␤ bond of the side chain of Thr480 (Fig. 7) . The lengths and angles of these H-bonds are summarized in Table 2 . Qualitatively, a change is seen whereby a protein/protein H-bond (Thr480-Arg485) is replaced by two H-bonds from these side chains to the ligand, glutamate. It should be noted that a similar flipping of Thr480 was not seen during the kainate simulation, possibly due to the presence of the ring in the ligand allowing less flexibility in the binding site.
FIGURE 4 Backbone torsion angles as a function of time for simulation Glu2 (starting with monomer C from the crystal structure). (A) of Ser652; (B) of Gly653. In the crystal structure there are three monomers (see text) with corresponding torsion angles: Ser652A, ϭ ϩ118°; Gly653A, ϭ ϩ167°; Ser652B, ϭ ϩ53°; Gly653B, ϭ Ϫ138°; Ser653C, ϭ ϩ27°; and Gly653C, ϭ Ϫ125°.
FIGURE 5 Key interactions of the binding sites for the glutamate and kainate binding sites, respectively. The structures are the minimized ones before the start of the restrained run. The diagram was generated with the program LIGPLOT (Wallace et al., 1995) . We have analyzed the energetics of these binding modes. The enthalpic energy difference between the two different binding modes for glutamate is not significant. An accurate value for the enthalpic binding energy between glutamate and kainate is not possible from these simulations, but an approximate calculation reveals that the difference is substantial (of the order of 100 kcal/mol).
DISCUSSION
The main achievements of these simulations have been 1) to reveal a correlation between intra-domain mobility and receptor occupation, such that low mobility corresponds to occupancy by a full agonist, and 2) to show that binding of glutamate to the S1S2 protein may be strengthened beyond that present in the crystal by rotation of the Thr480 side chain. Thus, the simulations may reveal aspects of GluR activation additional to those observed in the x-ray structures.
The principal limitations of the simulations are their relatively short duration, a result of computational limitations for atomistic simulations of relatively large systems (ϳ40,000 atoms). This short duration is problematic with respect to two distinct areas. The first of these is that the activation event (from ligand binding to channel opening) is of the order of milliseconds, and it is thus unwise to extrapolate beyond these current results. The second consideration is that of statistical sampling. We have performed reasonably long simulations, but only one flipping event around the Thr480 C␣-C␤ bond is observed for example. Ideally one should run these simulations many more times to ensure greater confidence that the observed events are a significant property of the system. One would also like to be able to estimate how well conformation space has been sampled. We are quite certain that many more simulations would be needed to start to address this issue more fully.
Furthermore, even after extending the Apo2 simulation to 5 ns it was not possible to observe a conformational transition corresponding to domain opening in the absence of ligand. Comparisons of the different crystal structures provide clear evidence of domain opening/closure (Armstrong and Gouaux, 2000) . However, applying similar analyses (Hingefind (Wriggers and Schulten, 1997) and DynDom (Hayward and Berendsen, 1998) ) to any single simulation failed to reveal any movement of the domains that could be dissected into bilobal hinge motions. This also suggests that domain closure is on a much longer timescale than is accessible in current simulations. Indeed, a similar obser- (Humphrey et al., 1996) . vation was made for nanosecond simulations of an SH2-SH3 domain system (Young et al., 2001) , where domain movement was known to exist. Furthermore, it seems that rare events on this timescale may not be directly observable, but the collective motions that contribute to their behavior may well be (Tai et al., 2001) .
The other major limitation, shared with the x-ray studies, is that our studies are of the water-soluble S1S2 construct rather than the intact GluR2 protein. However, as shown and discussed in Armstrong and Gouaux (2000) , the binding curves for 3 H-AMPA and the IC 50 values for ligand displacements are very similar to longer S1S2 constructs (Chen and Gouaux, 1997) and to those for the full-length receptor (Keinänen et al., 1990) . Thus it seems likely that the pharmacological properties of the S1S2 construct parallel those of the GluR2 receptor per se. Intriguingly, although very speculative, we also analyzed the movement of the linker residues and surrounding regions. Although the RMSFs of the linker residues were very similar in all three simulations, the RMSF values of the surrounding residues ϳ20 residues either side of this linker region showed noticeably higher values for the apo simulation compared with the ligand-bound simulations. Remaining residues had indistinguishable RMSF values. In the full-length protein the linker region would connect to the transmembrane domain, and it is thus tempting to try to speculate how this may be related to channel gating, but this will require much longer simulation times to be able to investigate this with any confidence.
CONCLUSIONS
Our main conclusion is that it is important to consider the conformational dynamics of a receptor and to determine how ligand binding may modulate the dynamics. In particular, for the GluR2 it seems that agonist binding not only results in domain closure (as revealed crystallographically) but also results in a decrease in domain mobility (as revealed in simulations) and that the reduction in mobility is greater for a full than for a partial agonist. At a more microscopic level our simulations reveal an important sidechain flipping motion of a residue (Thr480) in the binding site that changes the mode of binding of the agonist (glutamate). This side-chain flip generates an alternative mode of binding not observed for kainate and not observed for glutamate in the crystal structures. Such an observation may have important consequences in the consideration of drug design. However, the timescale of the inter-domain motion is significantly longer than that which is obtainable by conventional MD. We are currently extending this work by using techniques more suited to longer timescales.
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